Literature DB >> 22662402

The Tower of London Test: different scoring criteria for diagnosing Alzheimer's disease and mild cognitive impairment.

Jonas Jardim de Paula1, Lafaiete Moreira, Rodrigo Nicolato, Luiz Armando de Marco, Humberto Côrrea, Marco Aurélio Romano-Silva, Edgar Nunes de Moraes, Maria Aparecida Bicalho, Leandro Fernandes Malloy-Diniz.   

Abstract

The Tower of London (TOL) is used for evaluating planning skills, which is a component of the executive functions. Different versions and scoring criteria were developed for this task, and some of them present with different psychometrical properties. This study aimed to evaluate two specific scoring methods of the TOL in diagnosing Mild Cognitive Impairment and probable Alzheimer's disease. The TOL total scores from 60 patients of each diagnosis were compared with the performance of 60 healthy-aged controls using receiver operating characteristics analysis and multinomial logistic regression. Krikorian method better diagnosed Alzheimer's disease, while Portellas's was better at discriminating healthy controls from Mild Cognitive Impairment, but were not efficient at comparing this last group with Alzheimer's patients. Regression analysis indicates that in addition to screening tests, TOL improves the classification of the three groups. The results suggest the two scoring methods used for this task may be useful for different diagnostic purposes.

Entities:  

Mesh:

Year:  2012        PMID: 22662402     DOI: 10.2466/03.10.13.PR0.110.2.477-488

Source DB:  PubMed          Journal:  Psychol Rep        ISSN: 0033-2941


  7 in total

1.  Clinical applicability and cutoff values for an unstructured neuropsychological assessment protocol for older adults with low formal education.

Authors:  Jonas Jardim de Paula; Laiss Bertola; Rafaela Teixeira Ávila; Lafaiete Moreira; Gabriel Coutinho; Edgar Nunes de Moraes; Maria Aparecida Camargos Bicalho; Rodrigo Nicolato; Breno Satler Diniz; Leandro Fernandes Malloy-Diniz
Journal:  PLoS One       Date:  2013-09-16       Impact factor: 3.240

2.  The most frequently used tests for assessing executive functions in aging.

Authors:  Camila de Assis Faria; Heloisa Veiga Dias Alves; Helenice Charchat-Fichman
Journal:  Dement Neuropsychol       Date:  2015 Apr-Jun

3.  Use of machine learning to predict cognitive performance based on brain metabolism in Neurofibromatosis type 1.

Authors:  Manuel Schütze; Danielle de Souza Costa; Jonas Jardim de Paula; Leandro Fernandes Malloy-Diniz; Carlos Malamut; Marcelo Mamede; Débora Marques de Miranda; Michael Brammer; Marco Aurélio Romano-Silva
Journal:  PLoS One       Date:  2018-09-07       Impact factor: 3.240

4.  Changes in executive function and gait in people with mild cognitive impairment and Alzheimer disease.

Authors:  Natália Oiring de Castro Cezar; Juliana Hotta Ansai; Marcos Paulo Braz de Oliveira; Danielle Chagas Pereira da Silva; Francisco Assis Carvalho Vale; Anielle Cristhine de Medeiros Takahashi; Larissa Pires de Andrade
Journal:  Dement Neuropsychol       Date:  2021 Jan-Mar

Review 5.  Higher-Level Executive Functions in Healthy Elderly and Mild Cognitive Impairment: A Systematic Review.

Authors:  Ilaria Corbo; Maria Casagrande
Journal:  J Clin Med       Date:  2022-02-23       Impact factor: 4.241

6.  Remission of cognitive deficits in Parkinson's disease: recovery from a nonamnestic mild cognitive impairment or psychiatric symptoms remission?

Authors:  Jonas Jardim de Paula; Marco Túlio Gualberto Cintra; Débora Marques Miranda; Maria Aparecida Camargos Bicalho; Edgar Nunes Moares; Leandro Fernandes Malloy-Diniz
Journal:  Case Rep Psychiatry       Date:  2012-11-05

7.  Planning ability impairments in probable Alzheimer's disease patients: Evidence from the Tower of London test.

Authors:  Corina Satler; Luiza Guimarães; Carlos Tomaz
Journal:  Dement Neuropsychol       Date:  2017 Apr-Jun
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.